This interactive case study will guide you through a scenario of a patient being treated with a CDK4/6 inhibitor for their diagnosis of metastatic breast cancer. Learn more about CDK4/6 inhibitors and patient selection in a safe, virtual environment that will also provide you complimentary practice resources curated for nurses just like you.
For more information on the resources discussed in the case study please visit our CDK4/6 Inhibitor Learning Library.
You will enjoy access for 90 days from date of purchase, after which you will no longer be able to access the course.
Funding for development of this activity was provided by an independent educational grant from Pfizer Inc.
Learner will report an increase in knowledge in regards to choosing the appropriate CDK4/6 inhibitor for a patient with HR+, HER2-, advanced or metastatic breast cancer.
Content in this learning activity is applicable to meeting individual requirements for certification renewal through the Oncology Nursing Certification Corporation's Individual Learning Needs Assessment (ILNA) renewal method.
Up to .50 ILNA points may be applied to Treatment.
No more than .50 total points may be claimed for the program.
For optimal performance, and to fully participate in ONS online courses, it will be necessary to use one of the browsers listed below.
Supported Browsers for Desktop or Laptop Computers*:
*Use of an earlier version will prohibit the ability to post discussions or view some materials within the course properly.
After upgrading to one of these supported browser versions, please ensure your computer is set up to support the following additional requirements before beginning the lessons.
**If you're using a work computer for your course, the installation of these components may require assistance from the IT department at your place of business.